GL
Globe Life Inc
NYSE: GL · FINANCIAL SERVICES · INSURANCE - LIFE
$153.86
+3.16% today
Updated 2026-06-05
Market cap
$12.95B
P/E ratio
11.53
P/S ratio
2.13x
EPS (TTM)
$14.46
Dividend yield
0.69%
52W range
$116 – $168
Volume
0.5M
Globe Life Inc (GL) Financial Forecast & Price Target 2030
Research-backed projections from analyst consensus, management guidance, and sector analysis.
Research-backed GL price target 2030 projection accounting for share dilution, balance sheet debt, and time value of money.
Current price
$153.86
Today
Analyst consensus
$172.67
+12.23% · 12M
2030 Base
$155.09
+0.80% future
NPV today
$112.08
@ 7% WACC
11 analysts:
7 Buy2 Hold0 Sell
Management guidance
Globe Life has not provided explicit multi-year revenue targets through 2030. Management reaffirmed 2024 earnings guidance following Q1 2026 results and emphasized its strong core US protection business. The company is implementing strategic initiatives including a Bermuda reinsurance affiliate to enhance financial flexibility and free cash flow.
Sources: Management guidance, analyst consensus, sector analysishigh confidence
GL · Globe Life Inc · Revenue & price projection · 2023–2030E
Actual / 2030 target Projected revenue Base case price Bull to bear range
Bear case (2030)
$155.09
NPV today: $112.08
Base case (2030)
$155.09
NPV today: $112.08
Bull case (2030)
$261.44
NPV today: $188.93
WallStSmart.com
GL financial forecast · Research-backed projections
| Metric | 2025 | 2026 (E) | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) ★ |
|---|---|---|---|---|---|---|
| Revenue | $6.0B | $6.6B | $7.1B | $7.5B | $8.0B | $8.3B |
| Revenue growth | 3.8% | 10.2% | 7.6% | 6.3% | 5.4% | 4.8% |
| Net margin | — | 18.9% | 19.6% | 19.9% | 20.0% | 20.1% |
| EPS | $14.54 | $16.07 | $17.85 | $19.20 | $20.35 | $21.40 |
| Diluted shares | — | 78M | 78M | 78M | 78M | 78M |
| Net debt | — | $1.57B | $329.22M | $-985.22M | $-2.37B | $-3.82B |
| P/S multiple | — | 1.0x | 1.0x | 1.0x | 1.0x | 1.0x |
| Implied price (base) | — | $64.71 | $86.85 | $109.27 | $132.00 | $155.09 |
★ 2030E is the model's terminal target year. Implied price = (Revenue × P/S − Net debt) ÷ Diluted shares.
Scenario detail · Three drivers, three outcomes
| 2030E driver | Bear | Base | Bull |
|---|---|---|---|
| Revenue | $8.3B | $8.3B | $8.3B |
| P/S multiple | 1.0x | 1.0x | 2.0x |
| Diluted shares | 78M | 78M | 78M |
| Net debt | $-3.82B | $-3.82B | $-3.82B |
| Implied P/E † | 7x | 7x | 12x |
| 2030 Price | $155.09 | $155.09 | $261.44 |
| NPV @ 7% | $112.08 | $112.08 | $188.93 |
† Implied P/E: Multiples remain elevated across all three scenarios because GL is valued primarily on revenue scale during its growth phase, not near-term earnings power. Lower P/E in the bear case reflects multiple compression, but the absolute level stays high since 2030E still represents a hypergrowth-to-mature transition year.
EV to per-share bridge · How we get to $155.09 base case
GL catalysts and risks
Growth catalysts
+ Bermuda reinsurance affiliate deployment to improve free cash flow and capital efficiency
+ Continued premium growth from core US protection business (life and supplemental health insurance)
+ Medicare supplement market tailwinds supporting mid-market distribution channels
+ Resolution of regulatory scrutiny and short-seller allegations could re-rate stock upward
+ Potential dividend growth given 9.17% 3-year dividend growth rate and 7.68% payout ratio
Key risks
- Ongoing regulatory investigations and short-seller scrutiny impacting stock sentiment
- Interest rate volatility affecting investment income (19.4% profit margin sensitive to rates)
- Competitive pressures in life insurance from larger players (MetLife, Prudential, Lincoln National)
- Medical cost inflation impacting supplemental health insurance underwriting margins
- Demographic headwinds in traditional life insurance as younger cohorts prefer alternative products
Methodology · Globe Life Inc 2030 stock forecast model
Globe Life Inc 2030 price target is calculated using WallStSmart's research model. Revenue projections are derived from analyst consensus across 11 Wall Street analysts, management guidance from the latest earnings call, and sector growth forecasts. The model is built on five core components:
| 1. Share dilution | Projected from per-ticker schedule of SBC + equity raise activity, compounding year by year (1% cumulative for GL by 2030) |
| 2. Net debt | EV minus net debt yields equity value; debt projected from capex cycle trajectory ($-3.82B by 2030) |
| 3. Time value | NPV calculated using 7% WACC (CAPM: beta 0.5) |
| 4. Multiple framework | P/S compresses with scale: bear 1.0x / base 1.0x / bull 2.0x |
| 5. Scenario design | Bull/Base/Bear vary revenue, margin, shares, debt, and multiple independently |
WallStSmart research model · Not financial advice · Past performance is not indicative of future results · Last researched: May 21, 2026.
GL price target FAQ
What is the GL price target for 2030?
WallStSmart's Globe Life Inc 2030 base case is $155.09 per share, with a bull case of $261.44 and bear case of $155.09. The NPV of the base case discounted to today at 7% WACC is $112.08.
How is the Globe Life Inc 2030 stock forecast calculated?
The GL 2030 projection multiplies projected revenue by a growth-adjusted P/S multiple to derive enterprise value, subtracts projected net debt to get equity value, then divides by diluted shares outstanding accounting for dilution from stock-based compensation and equity raises.
Why does the GL price target account for dilution?
Globe Life Inc is projected to grow diluted share count from 78M to 78M by 2030 (a 1% increase) through stock-based compensation and capital raises. Ignoring this would inflate the price target by approximately 1%.
What is the analyst consensus on GL stock?
11 analysts cover GL with an average 12-month price target of $172.67. The 2030 projection extends this framework with longer-horizon assumptions including dilution and time value of money.